首页 正文

Circulating DNA tumor fraction as a biomarker for advanced breast cancer

{{output}}
Liquid biopsy has emerged as an important clinical tool for managing a range of tumor types, including advanced breast cancers. Early work in metastatic breast cancer (MBC) demonstrated that circulating tumor DNA (ctDNA) could be reliably detected in patient p... ...